The United States has approved breakthrough gene editing therapy using the CRISPR tool to treat sickle cell disease. This is a major advancement in gene therapy for patients with sickle cell disease, which affects over 100,000 Americans, mostly Black individuals. The therapy was approved by the US Food and Drug Administration and uses Nobel Prize-winning…
Dr Rosalind Eggo, an Associate Professor at LSHTM, has been awarded over £1.9 million in funding to research health disparities and associated infectious disease burden across England. Health disparities are preventable differences in health outcomes based on factors like income, ethnicity, education, age, gender, or disability. The research will analyze health records for over 20…
The article discusses the benefits and popularity of no-spray, pesticide-free Christmas trees among environmentally concerned customers. It highlights the success of Reed Island Christmas Tree Farm in southern Virginia, which offers eco-friendly trees that attract hundreds of customers. The article also emphasizes that the practice of organic tree farming, such as at Reed Island, is…
The FDA approved two gene-editing treatments for patients aged 12 years or older with severe sickle cell disease, marking the first cell-based gene therapies for the condition. Exa-cel uses CRISPR gene-editing technology and demonstrated success in a clinical trial, while Lovo-cel uses a different technology and also showed positive results. Both treatments were found to…
Researchers conducted a study on the manipulation of gut microbiota using flaxseeds and found that it could be beneficial in the prevention of breast cancer. Flaxseed is known for various health benefits, including relieving constipation, controlling cholesterol levels, and reducing inflammation. The study revealed that flaxseeds contain phytoestrogens called lignans that could influence the relationship…
